Clinical Trials Directory

Trials / Conditions / Myelogenous Leukemia, Acute

Myelogenous Leukemia, Acute

9 registered clinical trials studyying Myelogenous Leukemia, Acute — 1 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingRadioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML
NCT07157514
Actinium PharmaceuticalsPhase 2 / Phase 3
UnknownBisantrene Combination for Resistant AML
NCT04989335
Sheba Medical CenterPhase 2
Active Not RecruitingStudy of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leu
NCT02665065
Actinium PharmaceuticalsPhase 3
CompletedA Study of RO5503781 as a Single Agent or in Combination With Cytarabine in Participants With Acute Myelogenou
NCT01773408
Hoffmann-La RochePhase 1
CompletedA Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
NCT01641250
Hoffmann-La RochePhase 1
CompletedA Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
NCT01635296
Hoffmann-La RochePhase 1
TerminatedStudy of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247)
NCT00907517
Merck Sharp & Dohme LLCPhase 1
TerminatedMGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Di
NCT00374296
Mirati Therapeutics Inc.Phase 2
CompletedStudy of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia
NCT00130702
Dana-Farber Cancer InstitutePhase 2